MMP1 and familial pancreatic carcinoma: Consistent with their presumptive role as biomarkers, we have identifed MMP-1,-3,-7,-9,-10 and 12 as being upregulated in the serum of patients with pancreatic cancer, as compared to a cohort of healthy donors.